Difficult catheter access to the occluded vessel during endovascular treatment of acute ischemic stroke is associated with worse clinical outcome.
Marc Ribo, Alan Flores, Marta Rubiera...
https://pubmed.ncbi.nlm.nih.gov/23117130/Actively Recruiting
Led by Region Skane · Updated on 2026-03-04
300
Participants Needed
4
Research Sites
N/A
Total Duration
Researchers are evaluating the use of fusion imaging during endovascular thrombectomy EVT procedures for acute ischemic stroke caused by large vessel occlusion. This study aims to assess whether fusion imaging can improve target vessel access, increase recanalization success rates, and reduce procedure times compared to standard EVT. Fusion imaging involves combining 3D reconstructions from preprocedural CT angiography with live 2D angiography during the procedure. Participants will be randomly assigned to receive either standard EVT with fusion imaging or standard EVT without fusion imaging. Fusion imaging is performed using the ARTIS Icono Biplane system and includes steps such as importing CT angiography images, removing bone structures, and overlaying vascular landmarks onto live fluoroscopy. The fusion process is done quickly during patient preparation and does not add radiation or prolong the procedure. The study is multinational and multicenter, enrolling approximately 300 patients. During the study, researchers will collect data from national or local quality registries or a study database. They will monitor procedure success rates, vessel access, recanalization times, and other outcomes using imaging core lab adjudication. Safety is monitored, but fusion imaging does not add procedural risk or radiation exposure. The study lasts until three months after the last patient is included, and participant data is handled securely and anonymously.
CONDITIONS
Fusion Imaging in Endovascular Thrombectomy for Acute Ischemic Stroke
J
Johan Wasselius, MD, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Region Skane
Lead Sponsor
Örebro Läns Landsting
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Procedure duration on the day of treatment
Participants undergo an endovascular thrombectomy procedure either with Fusion imaging or standard treatment without Fusion.
1 procedure visit (in-person)
Duration - Up to 3 months after the procedure
Participants are monitored after the procedure using local or national quality registries and medical records for safety and outcome assessment.
Data collected from medical records and registries; no additional visits required
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Marc Ribo, Alan Flores, Marta Rubiera...
https://pubmed.ncbi.nlm.nih.gov/23117130/Kyoung Min Jang, Hyun Ho Choi, Taek Kyun Nam...
https://pubmed.ncbi.nlm.nih.gov/34823155/Brian M Snelling, Samir Sur, Sumedh S Shah...
https://pubmed.ncbi.nlm.nih.gov/30196176/Joaquin Penide, Mahmood Mirza, Ray McCarthy...
https://pubmed.ncbi.nlm.nih.gov/34642788/Urs Fischer, Johannes Kaesmacher, Daniel Strbian...
https://pubmed.ncbi.nlm.nih.gov/35810756/William J Powers, Alejandro A Rabinstein, Teri Ackerson...
https://pubmed.ncbi.nlm.nih.gov/31662037/Johan Wassélius, Emma Hall, Birgitta Ramgren...
https://pubmed.ncbi.nlm.nih.gov/38646674/Mayank Goyal, Bijoy K Menon, Wim H van Zwam...
https://pubmed.ncbi.nlm.nih.gov/26898852/Orgest Lajthia, Eyad Almallouhi, Hamid Ali...
https://pubmed.ncbi.nlm.nih.gov/36670537/Lovisa Landström, Emma Hall, Björn M Hansen...
https://pubmed.ncbi.nlm.nih.gov/41573710/Region Skane
Lead Sponsor
Örebro Läns Landsting
Collaborating Sponsor